Radium-223 might benefit patients with hormone-refractory prostate cancer

被引：0
|
作者：
机构：
来源：
Nature Clinical Practice Urology | 2007年 / 4卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：523 / 524
页数：1
相关论文
共 50 条
  • [1] Radium-223 might benefit patients with hormone-refractory prostate cancer
    不详
    NATURE CLINICAL PRACTICE UROLOGY, 2007, 4 (10): : 523 - 524
  • [2] Radium-223 for men with hormone-refractory prostate cancer and bone metastases
    Shelley, Mike D.
    Mason, Malcolm D.
    LANCET ONCOLOGY, 2007, 8 (07): : 564 - 565
  • [3] Radium-223 dichloride in patients with castration-refractory prostate cancer
    Winter, B. M.
    von Rundstedt, F. -C.
    Grimm, M. -O.
    UROLOGE, 2017, 56 (11): : 1435 - 1439
  • [4] Radium-223 in Prostate Cancer
    Biersack, Hans-Juergen
    Ezziddin, Samer
    Knapp, Furn F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (17): : 1659 - 1659
  • [5] Utilization of Radium-223 in Metastatic Prostate Cancer Patients and Novel Prognostic Indicators In Radium-223 Patients
    Parsons, M. W.
    Tward, J. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E899 - E899
  • [6] Radium-223 for the treatment of prostate cancer
    Hafeez, Shaista
    Parker, Christopher
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (03) : 379 - 387
  • [7] Prostate cancer - Therapy with radium-223
    Brito, Ana Emilia
    Amorim, Barbara Juarez
    Martello, Milena
    Bernardo, Wanderley Marques
    Etchebehere, Elba
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2017, 63 (12): : 1019 - 1023
  • [8] Radium-223 (Xofigo) for Prostate Cancer
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2013, 55 (1426): : 79 - 80
  • [9] Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer:: a randomised, multicentre, placebo-controlled phase II study
    Nilsson, Sten
    Franzen, Lars
    Parker, Christopher
    Tyrrell, Christopher
    Blom, Rene
    Tennvall, Jan
    Lennernas, Bo
    Petersson, Ulf
    Johannessen, Dag C.
    Sokal, Michael
    Pigott, Katharine
    Yachnin, Jeffrey
    Garkavij, Michael
    Strang, Peter
    Harmenberg, Johan
    Bolstad, Bjorg
    Bruland, Oyvind S.
    LANCET ONCOLOGY, 2007, 8 (07): : 587 - 594
  • [10] Radium-223 dichloride bone-targeted alpha particle therapy for hormone-refractory breast cancer metastatic to bone
    Takalkar A.
    Adams S.
    Subbiah V.
    Experimental Hematology & Oncology, 3 (1)
12345